Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping
Moritz Jesinghaus(Philipps University of Marburg), Melanie Boxberg(Starnberg Hospital), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung), Katja Ott(Technical University of Munich), Björn Konukiewitz(University Hospital Schleswig-Holstein), Nicole Pfarr(Technical University of Munich), Marcus Bettstetter, Julia Slotta‐Huspenina(Technical University of Munich), Rupert Langer(Johannes Kepler University of Linz), Petra Meyer(Technical University of Munich), Katja Specht(Technical University of Munich), Markus Feith(TUM Klinikum), Katja Steiger(Technical University of Munich), Kathrin Wieczorek(Technische Universität Dresden), Enken Drecoll
Cited by 51
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
|The Lancet Oncology|2007|808
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
|Journal of Clinical Oncology|2010|714
Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction
|Journal of Clinical Oncology|2006|464